Skip to main content
. 2023 Jul 11;28(4):293–299. doi: 10.4103/jiaps.jiaps_49_23

Table 1.

The trend in laboratory parameters in the cohort during pre- and postoperative follow-up

Variables Median (minimum–maximum) P

Preoperative 2 weeks postoperative 3 months postoperative 6 months postoperative 9 months postoperative 12 months postoperative
Hb (g/dL) 11.5 (10–12.2) 10.3 (8–11.6) 10.9 (8.5–12.4) 10.8 (8.7–16.7) 11.1 (9–12) 11.9 (9.2–12.2) 0.159
TLC (109/L) 11.6 (7–14.7) 9.8 (8.6–12.9) 9.2 (6–11.3) 9.1 (5–12.1) 8.5 (5.8–10) 9 (7–11) 0.173
PLT (109/L) 384 (170–564) 376 (174–582) 345 (174–488) 318 (138–365) 280 (102–369) 286 (152–311) 0.503
INR 1.09 (1–1.1) 1.1 (1.1–1.13) 1.1 (1–1.13) 1.1 (1–1.13) 1.1 (1.01–1.12) 1.1 (1.07–1.12) 0.194
PC (%) 90.6 (87–100) 91 (84.7–97) 90.3 (83.9–99) 84 (64–99) 87 (84–99) 89 (79.5–96.5) 0.099
Bilirubin total 11.9 (2.9–20.9) 10.3 (2–21.4) 10.5 (2.8–25.1) 9.9 (2.7–17.9) 9.7 (2.2–18.8) 12.1 (9–24.7) 0.121
Bilirubin direct 10 (1.5–19.2) 5.6 (1.5–11.2) 7.5 (1.6–14.5) 6.5 (1.2–11.8) 6.1 (1.36–12) 7.9 (4.8–19.1) 0.361
AST (U/L) 205 (31–336) 181 (62–328) 174 (56–639) 183 (48–305) 208 (167–263) 249 (193–288) 0.67
ALT (U/L) 145 (34–219) 146 (44–363) 138 (34–383) 162 (31–251) 230 (165–343) 206 (167–263) 0.361
GGT (U/L) 69 (22–574) 70 (27–537) 98 (23–637) 91 (21–533) 149 (39–517) 68 (37–457) 0.617
ALP (U/L) 593 (314–1113) 324 (262–779) 526 (257–1043) 537 (323–1010) 491 (347–1016) 413 (330–330) 0.267
Albumin (mg/dL) 3.4 (2.1–3.8) 3.5 (3–4.9) 3.5 (2.2–4.6) 3.7 (2.6–4.83) 3.6 (2.8–4.3) 3.7 (2.9–3.9) 0.059
Bile salt (umol/L) 154 (29.5–216) 80.5 (18.4–110) 80 (14–104) 0.013*
Cholesterol (mg/dL) 132 (76–734) 100.5 (69–315) 0.59

P <0.05 was considered statistically significant, Hb: Hemoglobin, TLC: Total leucocyte count, PLT: Platelets, INR: Internationalized ratio, PC: Prothrombin concentration, AST: Aspartate aminotransferase, ALT: Alanine amino transferase, ALP: Alkaline phosphatase, GGT: Gamma-glutamyl transferase